Azione INDEX INDEX PHARMACEUTICALS HOLDING AB
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue InDex Pharmaceuticals Holding AB

Azioni

INDEX

SE0008966295

Mercato chiuso - Nasdaq Stockholm
Altri mercati azionari
 17:13:57 15/04/2024 		Variaz. 5gg Var. 1 gen.
0,327 SEK -0,91% Grafico intraday di InDex Pharmaceuticals Holding AB -2,39% +27,73%
05/04 Index Pharmaceuticals Holding AB (Publ) annuncia le dimissioni del Consiglio di Amministrazione CI
26/03 L'amministratore delegato e il direttore finanziario di InDex Pharmaceuticals si dimettono in seguito alla cessazione delle operazioni MT

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
InDex Pharmaceuticals provides a company update
InDex Pharmaceuticals Holding AB (publ) publishes Annual Report for 2023
Notice of Annual General Meeting in InDex Pharmaceuticals Holding AB (publ)
Index Pharmaceuticals Holding AB Announces Board Resignations
InDex Pharmaceuticals CEO, CFO to Step Down as Operations Cease
CEO and CFO both to leave InDex Pharmaceuticals
Index Pharmaceuticals Holding AB Announces Resignation of Johan Giléus as Deputy CEO
InDex Pharmaceuticals Holding AB Announces Resignation of Jenny Sundqvist as CEO, Effective September 26, 2024
InDex Pharmaceuticals Holding AB Announce Resignation of Johan Giléus as CFO, Effective September 26, 2024
InDex Pharmaceuticals Launches Strategic Review Amid Decision to Stop Cobitolimod Development
InDex Pharmaceuticals provides an update on company's future
InDex Pharmaceuticals discontinues the development of cobitolimod
InDex Pharmaceuticals Holding AB Discontinues the Development of Cobitolimod
InDex Pharmaceuticals Holding AB (publ) year-end report 2023
InDex Pharmaceuticals Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023
InDex Pharmaceuticals Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
InDex Pharmaceuticals announces expected cash balance per March 31, 2024
InDex Pharmaceuticals Holding AB interim report January-September 2023
InDex Pharmaceuticals Q3 2023 - Uncertain future post discontinuation of CONCLUDE
InDex Pharmaceuticals Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione INDEX
  4. Notizie InDex Pharmaceuticals Holding AB
  5. Altre lingue